購物車
幫助
021-54845833/15800441009
宿 主： Rabbit
技術規(guī)格
|
Background: |
This gene encodes a zinc metallopeptidase that degrades intracellular insulin, and thereby terminates insulins activity, as well as participating in intercellular peptide signalling by degrading diverse peptides such as glucagon, amylin, bradykinin, and kallidin. The preferential affinity of this enzyme for insulin results in insulin-mediated inhibition of the degradation of other peptides such as beta-amyloid. Deficiencies in this protein's function are associated with Alzheimer's disease and type 2 diabetes mellitus but mutations in this gene have not been shown to be causitive for these diseases. This protein localizes primarily to the cytoplasm but in some cell types localizes to the extracellular space, cell membrane, peroxisome, and mitochondrion. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described but have not been experimentally verified. |
|
Applications: |
ELISA, WB, IHC |
|
Name of antibody: |
IDE |
|
Immunogen: |
Fusion protein of human IDE |
|
Full name: |
insulin-degrading enzyme |
|
Synonyms: |
INSULYSIN |
|
SwissProt: |
P14735 |
|
ELISA Recommended dilution: |
2000-5000 |
|
IHC positive control: |
Human colon cancer and Human tonsil |
|
IHC Recommend dilution: |
10-50 |
|
WB Predicted band size: |
118 kDa |
|
WB Positive control: |
K562 cells |
|
WB Recommended dilution: |
500-2000 |
